B
Bobby B. Najari
Researcher at New York University
Publications - 55
Citations - 959
Bobby B. Najari is an academic researcher from New York University. The author has contributed to research in topics: Population & Vasectomy. The author has an hindex of 11, co-authored 52 publications receiving 710 citations. Previous affiliations of Bobby B. Najari include NewYork–Presbyterian Hospital & Cornell University.
Papers
More filters
Journal ArticleDOI
Spermatogenesis in humans and its affecting factors.
TL;DR: In this review, the critical steps of human spermatogenesis are discussed together with its main affecting factors.
Journal ArticleDOI
Testosterone replacement therapy following radical prostatectomy.
Mohit Khera,Ethan D. Grober,Bobby B. Najari,John S Colen,Osama Mohamed,Dolores J. Lamb,Larry I. Lipshultz +6 more
TL;DR: TRT is effective in improving testosterone levels, without increasing PSA values, in hypogonadal men who have undergone RP and also to evaluate the impact of pathologic Gleason grade on ultimate PSAvalues.
Journal ArticleDOI
The quantitative ADAM questionnaire: a new tool in quantifying the severity of hypogonadism
Osama Mohamed,Robert E. Freundlich,H K Dakik,Ethan D. Grober,Bobby B. Najari,Larry I. Lipshultz,Mohit Khera +6 more
TL;DR: The qADAM represents a viable alternative to existing questionnaires used to detect androgen deficiency and to assess response to treatment and is reported to be successful use in quantifying the severity of androgens deficiency in a group of older men.
Journal ArticleDOI
Genetics of Male Infertility.
TL;DR: Clinical aspects of male infertility and the role of genetics in elucidating etiologies and the potential of treatments are focused on.
Journal ArticleDOI
Trends in the Utilization of Penile Prostheses in the Treatment of Erectile Dysfunction in the United States
Daniel J. Lee,Bobby B. Najari,Wesley Davison,Fujun Zhao,Darius A. Paduch,John P. Mulhall,Bilal Chughtai,Richard K. Lee +7 more
TL;DR: The surgical management of ED with PP changed significantly between 2001 and 2010, and the overall utilization of PP decreased, but its use in patients with significant medical comorbidities increased.